Cigna Group (NYSE:CI) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Cigna Group (NYSE:CI) has been given a consensus rating of “Moderate Buy” by the twenty-three ratings firms that are presently covering the company, Marketbeat Ratings reports. Eight investment analysts have rated the stock with a hold recommendation and fifteen have issued a buy recommendation on the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $337.0952.

Several equities research analysts have commented on CI shares. Mizuho boosted their price target on shares of Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th. UBS Group lifted their target price on Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a research report on Friday, May 22nd. Piper Sandler dropped their target price on Cigna Group from $370.00 to $346.00 and set an “overweight” rating on the stock in a report on Wednesday, June 3rd. Weiss Ratings reissued a “hold (c)” rating on shares of Cigna Group in a research report on Thursday, August 27th. Finally, Robert W. Baird set a $362.00 price target on Cigna Group in a research note on Friday, July 31st.

Insider Activity at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 19,436 shares of the firm’s stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total value of $5,369,583.72. Following the sale, the insider owned 27,256 shares in the company, valued at $7,530,015.12. This trade represents a 41.63% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the firm’s stock in a transaction on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the sale, the insider directly owned 5,053 shares in the company, valued at approximately $1,435,304.65. This trade represents a 10.88% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 22,730 shares of company stock valued at $6,293,359 over the last 90 days. Corporate insiders own 0.60% of the company’s stock.

Hedge Funds Weigh In On Cigna Group

A number of hedge funds have recently made changes to their positions in the stock. Evercore Wealth Management LLC increased its holdings in Cigna Group by 2.8% in the first quarter. Evercore Wealth Management LLC now owns 1,301 shares of the health services provider’s stock worth $347,000 after purchasing an additional 35 shares in the last quarter. Cary Street Partners Investment Advisory LLC boosted its holdings in shares of Cigna Group by 11.0% during the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 363 shares of the health services provider’s stock worth $100,000 after buying an additional 36 shares in the last quarter. Independence Bank of Kentucky grew its position in shares of Cigna Group by 2.6% during the 2nd quarter. Independence Bank of Kentucky now owns 1,483 shares of the health services provider’s stock worth $409,000 after buying an additional 37 shares during the period. West Family Investments Inc. grew its position in shares of Cigna Group by 4.2% during the 2nd quarter. West Family Investments Inc. now owns 919 shares of the health services provider’s stock worth $253,000 after buying an additional 37 shares during the period. Finally, IHT Wealth Management LLC increased its stake in shares of Cigna Group by 2.5% in the 4th quarter. IHT Wealth Management LLC now owns 1,535 shares of the health services provider’s stock valued at $423,000 after acquiring an additional 38 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors.

Cigna Group Trading Down 0.1%

NYSE:CI opened at $280.51 on Friday. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. Cigna Group has a 1-year low of $239.51 and a 1-year high of $315.47. The firm has a market capitalization of $74.12 billion, a price-to-earnings ratio of 11.61, a PEG ratio of 0.96 and a beta of 0.31. The business’s 50-day moving average price is $283.31 and its two-hundred day moving average price is $280.78.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. During the same period last year, the business posted $7.20 earnings per share. The business’s revenue for the quarter was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, equities analysts expect that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is presently 25.82%.

Cigna Group Company Profile

The Cigna Group (NYSE: CI) is a global health services company that helps individuals, employers, health plans and government organizations access health care and related services. The company operates primarily through two businesses: Cigna Healthcare, which provides medical, behavioral health, dental and other health benefit products and services, and Evernorth Health Services, which offers pharmacy, care delivery and health benefits solutions.

Evernorth includes Express Scripts, a pharmacy benefit services provider that manages prescription drug benefits and operates home delivery and specialty pharmacy services.